Trial Profile
Phase I safety study of DP VPA.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 16 Apr 2015
Price :
$35
*
At a glance
- Drugs DP-VPA (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- Sponsors Jiangsu Nhwa Pharmaceutical
- 16 Apr 2015 New trial record